Skip to content

Clinical trials

Terminated Phase 1/2 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20162
20181
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center1
Fusion Pharmaceuticals Inc.1
Kathy Miller1
M.D. Anderson Cancer Center1
Nanobiotix1
National Cancer Centre, Singapore1
National Cancer Institute (NCI)1
Omega Therapeutics1
Radboud University Medical Center1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms11
Carcinoma, Hepatocellular5
Breast Neoplasms2
Colorectal Neoplasms2
Kidney Neoplasms2
Lung Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Recurrence2
Stomach Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.